News

Filter

1 to 9 of 61 results

SOBI granted marketing authorization for Xiapex in Peyronie's disease in the EU

SOBI granted marketing authorization for Xiapex in Peyronie's disease in the EU

02-02-2015

Nordic biotech firm Swedish Orphan Biovitrum (STO: SOBI) has received approval from the European Commission…

Men's HealthPharmaceuticalRegulationSobiXiaflexXiapex

Erectile dysfunction and diabetes drugs to be tested as dementia treatments

Erectile dysfunction and diabetes drugs to be tested as dementia treatments

12-12-2014

The Alzheimer's Drug Discovery Foundation (ADDF) and the Alzheimer's Society UK announced new funding…

CialisDiabetesEli LillyliraglutideMen's HealthNeurologicalNovo NordiskPharmaceuticalResearchTadalafilVictoza

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

24-11-2014

Trimel Biopharma, a subsidiary of Canada's Trimel Pharmaceuticals Corp, has signed an agreement with…

CanadaEndoLicensingMarkets & MarketingMen's HealthPharmaceuticalTrimel PharmaceuticalsUSA

Forendo licenses fispemifene to Apricus in USA

20-10-2014

Finland-based Forendo Pharma, a Swedish firm Karolinska Development portfolio company, has entered into…

Apricus BiosciencesfispemifeneForendo PharmaGenito-urinaryKarolinska DevelopmentLicensingMen's HealthPharmaceuticalUSA

Endo’s buy of struggling Auxilium for $2.6 billion analysed by GlobalData

12-10-2014

Endo International’s $2.6 billion purchase of Auxilium Pharmaceuticals (The Pharma Letter October 9)…

Auxilium PharmaceuticalsEndo InternationalMen's HealthMergers & AcquisitionsPharmaceuticalRare diseasesTestimTestopelXiaflex

Highlights from EMA Pharmacovigilance October meeting

10-10-2014

At its October meeting, the European Medicines Agency’ Pharmacovigilance Risk Assessment Committee…

Ariad PharmaceuticalsEuropeIclusigMen's HealthNeurologicalOncologyPharmaceuticalRegulationTestosteronevalproate

Auxilium Pharma succumbs to higher, $2.6 billion, offer from Endo

Auxilium Pharma succumbs to higher, $2.6 billion, offer from Endo

09-10-2014

Having previously rejected a $28.10 a share takeover offer from Ireland-headquartered Endo International,…

Auxilium PharmaceuticalsEndo InternationalIrelandMen's HealthMergers & AcquisitionsPharmaceuticalQLTUSA

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

22-09-2014

Auxilium Pharmaceuticals’ board of directors, after review of the unsolicited $2.2 billion takeover…

AuxiliumCanadaEndo InternationalMen's HealthMergers & AcquisitionsPharmaceuticalQLTUSA

1 to 9 of 61 results

COMPANY SPOTLIGHT

Menarini

Back to top